Genmab Market Cap

Genmab has a market cap or net worth of 106.28 billion as of March 6, 2026. Its market cap has increased by 8.61% in one year.

Market Cap

106.28B

Enterprise Value

129.89B

Revenue

23.66B

Ranking

n/a

PE Ratio

17.68

Stock Price

1,728.50

Market Cap Chart

Since October 18, 2000, Genmab's market cap has increased from 3.68B to 106.28B, an increase of 2,784.75%. That is a compound annual growth rate of 14.15%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	106.28B	-14.88%
Dec 30, 2025	124.86B	31.70%
Dec 30, 2024	94.81B	-32.65%
Dec 29, 2023	140.77B	-26.77%
Dec 30, 2022	192.23B	11.72%
Dec 30, 2021	172.06B	6.80%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Novo Nordisk	1,090.67B
Coloplast	104.48B
ALK-Abelló	49.41B
Demant	40.58B
H. Lundbeck	37.38B
Zealand Pharma	26.07B
Ambu A/S	20.61B
Bavarian Nordic	14.60B

Market Cap Rankings